Where is HEOR located?

HEOR is headquartered in Cardiff, United Kingdom. It is registered at 100 BOLDMERE ROAD,SUTTON COLDFIELD,WEST MIDLANDS,B73 5UB.

How many employees does HEOR have?

As of Apr 30, 2026, the latest employee count at HEOR is 131.

Is HEOR a funded company?

HEOR is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does HEOR rank among its competitors?

HEOR ranks 420th amongst 392 active competitors, of which 10 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Raynovent, which secured $53.6M in Jan, 2023.

Who are the top competitors of HEOR?

HEOR's top competitors include OPEN Health, Abacus Medicine and Bridge Medical. Among them, Raynovent secured the most recent funding round in January, 2023.

HEOR - 2026 Company Profile, Competitors & Financials

HEOR is an unfunded company based in Cardiff (United Kingdom), founded in 2011. It operates as a Provider of data collection, HEOR & market access services to biopharma sector. HEOR has not raised any funding yet. The company has 392 active competitors, including 10 funded and 45 that have exited. Its top competitors include companies like OPEN Health, Abacus Medicine and Bridge Medical.

Company Details

Website: heor.co.uk
Registered Address: 100 BOLDMERE ROAD,SUTTON COLDFIELD,WEST MIDLANDS,B73 5UB

Key Metrics

Founded Year

2011

Location

Cardiff, United Kingdom

Stage

Unfunded

Ranked

420^th among 453 competitors

Employee Count

131 as on Apr 30, 2026

Similar Companies

OPEN Health & 451 more

View HEOR's full profile

HEOR is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
HEOR LTD CIN: 8788859 , United Kingdom, Active	Nov 24, 2013	-	1 (As on Dec 01, 2019)

HEOR has not raised any funding rounds yet.

HEOR's employee count trend

HEOR has 131 employees as of Apr 26. Here is HEOR's employee count trend over the years:

Uncover HEOR's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of HEOR include OPEN Health, Abacus Medicine and Bridge Medical. Here is the list of Top 10 competitors of HEOR, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OPEN Health 2016, Marlow (United Kingdom), Acquired	Provider of healthcare marketing services	$5.28M	LBO France, Amulet Capital Partners	63/100
2nd	Abacus Medicine 2004, Copenhagen (Denmark), Series A	Consulting services for market access, health economics and outcomes research	$57.6M	Chr. Augustinus Factories	56/100
3rd	Bridge Medical 2011, Chatham (United Kingdom), Acquired	Provider of evidence and outcomes research for biopharmaceutical companies	-	-	50/100
4th	Secura Bio 2018, Henderson (United States), Series A	Provider of consulting services for market access and health outcomes	$55M	Athyrium Capital Management	48/100
5th	GBA Group 1975, Hamburg (Germany), Acquired	Provider of drinking water testing, environmental analysis, and marketing services to the pharmaceutical industry	-	Adiuva Capital	44/100
6th	Target RWE 2017, Durham (United States), Acquired	Provider of marketing services to the pharmaceutical industry	-	Norwest, VentureSouth	43/100
7th	BioPharm Communications 2005, New Hope (United States), Acquired	Provider of marketing services to pharmaceutical and biopharma companies	-	Abacus Finance Group, Boathouse Capital & 2 others	43/100
8th	Raynovent 2018, Guangzhou (China), Series C	Provider of marketing services	$53.6M	Efung Capital, Yide Fund & 6 others	43/100
9th	PHMR 2007, London (United Kingdom), Acquired	Provider of market access services	-	-	42/100
10th	Taevas Global 2019, Hyderabad (India), Unfunded	Provider of market entry and regulatory compliance services for life sciences companies	-	-	41/100
420th	HEOR 2011, Cardiff (United Kingdom), Unfunded	Provider of data collection, HEOR & market access services to biopharma sector	-	-	15/100